CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material (NCT07276711)
Controlled Arterial Protection to Ultimately Remove Embolic Material
🩺 Plain-English Summary (8th-Grade Level)
The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.
Who can join: Review the eligibility criteria below.
Location: Los Robles Regional Medical Center — Thousand Oaks, California
Age range: 22 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Los Robles Regional Medical Center — Thousand Oaks, California
- Morton Plant Hospital | BayCare Health — Clearwater, Florida
- Ochsner Medical Center — New Orleans, Louisiana
- University of Michigan Health | Michigan Medicine — Ann Arbor, Michigan
- Mission Health — Asheville, North Carolina
- Monument Health Heart and Vascular Institute — Rapid City, South Dakota
- Methodist Research Institute — San Antonio, Texas
📞 Contact the Study Coordinator
Phone: (763) 227-9954
Email: k.vo@emstopeps.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aortic Valve Stenosis
- ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis — Los Angeles, California
- Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation — Québec, Quebec
- Inspiris Resilia Durability Registry — Sankt Pölten,
- Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) — Chandler, Arizona
- Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Phoenix, Arizona
- Platelet Adhesion in the Pathobiology of Aortic Stenosis — Charlottesville, Virginia
Explore by condition: All Aortic Valve Stenosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.